<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000269428">
  <TermName>risedronate</TermName>
  <TermPronunciation>(rih-SEH-droh-nayt)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the prevention and treatment of osteoporosis. It belongs to the family of drugs called bone resorption inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000710063" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;risedronate&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000710064" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;risedronato&quot;" language="es" id="_4"/>
  <SpanishTermName>risedronato</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para la prevención y el tratamiento de la osteoporosis. Es un tipo de inhibidor de la reabsorción ósea.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2002-12-21</DateFirstPublished>
</GlossaryTerm>
